. | . |
China reports good progress in human bird flu vaccine Beijing (AFP) Dec 24, 2007 China has made good progress in developing a human vaccine against the deadly bird flu virus, with a second phase of tests showing it to be safe and effective, state press reported Monday. About 400 people aged between 18 and 60 who were given the vaccine between September and November this year had shown no ill side effects, and the drug had "performed well", Xinhua news agency said, citing an official involved. "China is capable of producing bird flu vaccines for humans in appropriate quantities," Zhang Jiansan, the vice general manager of Beijing-based vaccine producer Sinovac Biotech, was quoted as saying. The World Health Organisation gave a cautious response to the announcement. "Around a year ago China announced the first phase of clinical tests for a human vaccine," a Beijing-based WHO spokeswoman said in an e-mail to AFP. "It's encouraging that China is making progress but WHO needs more information to properly comment. We'll be talking to the Chinese researchers for more information." Many countries and firms have been developing vaccines to combat the H5N1 strain of the bird flu, which has killed more than 200 people worldwide, mostly in Southeast Asia, since late 2003. Seventeen people have died of the bird flu in China. Scientists have warned that the virus could kill many more people around the world if it mutates into a form that can be easily passed among humans, rather than from poultry to people as is now the case. But WHO assistant director general David Heymann said this month in Geneva there was no need yet for a massive vaccine campaign against the bird flu virus because it has not been proven that it would become a pandemic. Community Email This Article Comment On This Article Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
Sea cucumber protein used to fight malaria London (UPI) Dec 21, 2007 British researchers say they've genetically engineered a mosquito to release a sea-cucumber protein into its gut to impair the development of malaria parasites. |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |